India court widens government power over costly patented medicines
By Freny Patel ( October 1, 2026, 11:06 GMT | Insight) -- Patented medicines could face greater government intervention after an Indian court ruled that unaffordable prices can trigger government use of pharmaceutical patents to supply drugs to patients.Patented medicines in India could face greater government intervention to address high prices after a domestic court ruled that the government-use provision of the Patents Act can be invoked when treatment becomes unaffordable because of a medicine’s cost....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.